PCOS is a complex hormonal disturbance in which women do not ovulate regularly, and their ovaries produce excessive quantities of male hormones, such as testosterone.
It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
